News
Media
Conference
Publications
Resources
Partners
Subscribe

Spotlight -

Geographic Atrophy

Robert A. Sisk, MD, FACS, FASRS

Cincinnati Eye Institute

Professor of ophthalmology at the University of Cincinnati

Articles by Robert A. Sisk, MD, FACS, FASRS

Q&A: 24-month results of the phase 2 SKYLINE trial for XLRP

ByRobert A. Sisk, MD, FACS, FASRS

August 2nd 2025

Latest Updated Articles

Q&A: 24-month results of the phase 2 SKYLINE trial for XLRP
August 2nd 2025

Trending on Modern Retina

Tinlarebant earns Swiss orphan drug status for Stargardt disease

Intracortical visual prosthesis: A new chapter in advancing visual restoration

Biogen completes acquisition of Apellis Pharmaceuticals